Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Profit After TaxShare-based Compensation (IS)Shares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Innate Pharma (IPHA) Other Operating Expenses (2024)

Historic Other Operating Expenses for Innate Pharma (IPHA) over the last 1 years, with Q4 2024 value amounting to -$0.0.

  • Innate Pharma's Other Operating Expenses changed N/A to -$0.0 in Q4 2024 from the same period last year, while for Jun 2025 it was -$0.0, marking a year-over-year change of. This contributed to the annual value of $41.8 million for FY2022, which is N/A changed from last year.
  • As of Q4 2024, Innate Pharma's Other Operating Expenses stood at -$0.0.
  • Innate Pharma's 5-year Other Operating Expenses high stood at -$0.0 for Q4 2024, and its period low was -$0.0 during Q4 2024.